To Be Discontinued Topical Powder Anti-Infective
Nystatin Topical Powder · 3 active FDA presentation rows for this drug
Brand: NYAMYC
FDA lists Nystatin Topical Powder as To Be Discontinued (Upsher-Smith Laboratories, LLC).
No availability text on this FDA row.
Nystatin Topical Powder: To Be Discontinued
FDA availability text is not recorded on this row. 3 shortage presentations are tracked for this drug. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Nystatin Topical Powder
- Manufacturer
- Upsher-Smith Laboratories, LLC
- Dosage Form
- Topical Powder
- Presentation
- Nystatin, Topical Powder, 100000 [USP'U]/1 g (NDC 0832-0465-30)
- Package NDC
- 0832-0465-30
Status & Timeline
- Status
- To Be Discontinued
- First Reported
- Apr 28, 2025
- Last Updated
- Apr 28, 2025
- Therapeutic Category
- Anti-Infective, Dermatology
Row fields from the FDA Drug Shortages database via openFDA.
Full Drug Profile
nystatin
Side effects, interactions, warnings & more